Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Kevin Cooper, MD

Kevin Cooper, MD

  • Chair, Department of Dermatology, UH Cleveland Medical Center
  • Professor of Dermatology, CWRU School of Medicine
  • Professor of Pathology, CWRU School of Medicine
  • Henri Pell Junod, Jr. Chair in Dermatology, University Hospitals
  • Specialty: Dermatology, Dermatology-Clinical and Lab Dermatological Immunology
  • Location:
    UH Cleveland Medical Center Bolwell
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Kevin Cooper, MD


  • Atopic Dermatitis (Eczema)
  • Cutaneous Lymphomas
  • Dermatology
  • Immunomodulatory Therapy
  • Inflammatory Skin Disorders
  • Melanoma
  • Psoriasis

Certifications & Memberships

  • Clinical and Laboratory Dermatological Immunology - American Board of Dermatology
  • Dermatology - American Board of Dermatology


Fellowship | Clinical and Laboratory Dermatological Immunology
Clinical and Laboratory Dermatological Immunology - National Institutes Of Health (1982 - 1985)

Fellowship | Immunodermatology
Immunodermatology - Oregon Health And Science University Hospital (1981 - 1982)

Residency | Dermatology
Dermatology - Oregon Health And Science University Hospital (1978 - 1981)

Internship | Dermatology
Dermatology - Oregon Health And Science University Hospital (1977 - 1978)

Medical Education
University Of Florida College Of Medicine (1977)

University Of Florida (1973)

Research & Publications

Research Links

View Research

Research Interests

Immunodermatology, cutaneous lymphoma research, translational research

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Kevin Cooper disclosed the following Outside Relationships with Industry:

  • - Fluence therapeutics - Ownership